Country Trust Bank Bristol Myers Squibb CO Transaction History

Country Trust Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$57.89 - $64.73 $13,025 - $14,564	225 New	225 $13,000
Q1 2023 Apr 13, 2023	BUY	$65.71 - $74.53 $15,770 - $17,887	240 New	240 $16,000
Q1 2022 Apr 25, 2022	SELL	$61.48 - $73.72 $4,119 - $4,939	-67 Reduced 49.63%	68 $5,000
Q4 2021 Jan 26, 2022	BUY	$53.63 - $62.52 $3,593 - $4,188	67 Added 98.53%	135 $8,000
Q2 2021 Jul 19, 2021	BUY	$61.91 - $67.42 $4,209 - $4,584	68 New	68 $5,000
Q1 2019 Apr 17, 2019	SELL	$45.12 - $53.8 $1,173 - $1,398	-26 Closed	0 $0
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $1,170 - $1,517	-24 Reduced 48.0%	26 $1,000
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $441 - $498	-8 Reduced 13.79%	50 $3,000
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $13.7 Million - $17.1 Million	-271,002 Reduced 99.98%	58 $3,000
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $2.62 Million - $3.02 Million	-43,712 Reduced 13.89%	271,060 $17.1 Million
Q4 2017 Jan 11, 2018	SELL	$59.94 - $65.35 $231,008 - $251,858	-3,854 Reduced 1.21%	314,772 $19.3 Million
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $17.6 Million - $20.3 Million	318,626	318,626 $20.3 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

Stay updated on Country Trust Bank with notifications on news.